Atlas Trials

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Clinical trial NCT03540420 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03540420
Sponsor
Norwegian University of Science and Technology
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Small-cell Lung Cancer
Start date
2018-07-31
Primary completion
2024-04-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.